Search results
Kim Kardashian’s Met Gala Look Had 1 Detail So Extreme It Made People Uncomfortable
HuffPost· 5 days agoKim Kardashian courted controversy at Monday’s Met Gala due to a very uncomfortable-looking aspect...
Stem cell treatments in Mexico linked to drug-resistant meningitis, joint infections - UPI.com
UPI· 4 days agoThe cases outlined in the new report began in late 2022, when a Colorado woman in her 30s showed up...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Horan Capital Advisors LLC.
ETF DAILY NEWS· 5 days agoHoran Capital Advisors LLC. lessened its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 1.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities ...
ARS Wealth Advisors Group LLC Increases Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoARS Wealth Advisors Group LLC raised its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 56.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The ...
Stelara interactions: Other medications, alcohol, and more
Medical News Today· 3 days agoStelara (ustekinumab) is a brand-name injectable drug prescribed for certain autoimmune conditions....
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace· 6 days agoPicking income stocks can be challenging. It varies year to year, but holding solid income stocks...
Higher NSAID Dose Raises CVD Risk in Ankylosing Spondylitis
Medscape· 3 days agoNSAIDs, the primary pain management therapy for AS, increased the risk for vascular events and...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 4 days ago“Our top priority is executing on our strategy to accelerate the development and delivery of transformative medicines for patients, and we are confident that we can accomplish this mission while ...
Johnson & Johnson (NYSE:JNJ) Shares Bought by ETF Store Inc.
ETF DAILY NEWS· 1 day agoETF Store Inc. raised its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 6.6% during the fourth quarter, according to the company in its most recent disclosure with the ...
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...
Rome Sentinel· 3 days agoAdalimumab-aaty is also available from Celltrion USA under the brand name YUFLYMA®, which launched in July 2023 and is available at a 5% discount to the current WAC list price of HUMIRA. Adalimumab-aaty ...